Nel ASA's Order Intake Jumps 339% While Revenue Falls 63%
Published on 10/24/2026 at 03:11 | Editorial boerse-global.de
Nel ASA has handed investors a puzzle rather than a verdict. Orders are pouring in at a pace not seen in recent quarters, yet the money actually booked from customers has shrunk dramatically. For anyone weighing the Norwegian hydrogen specialist, the question is no longer whether demand exists — it is whether that demand can be converted into revenue and, eventually, into profit.
The figures for the third quarter of 2026, released just over a week ago, capture that tension precisely. Order intake reached NOK 253 million, a 339% leap on the prior-year period. The order backlog stood at NOK 1,314 million at quarter-end. Against that, revenue from customer contracts collapsed 63% to NOK 112 million, while EBITDA came in at minus NOK 93 million and the net loss amounted to NOK 141 million. Cash at the close of the quarter was NOK 1,078 million.
A Backlog Is a Promise, Not a Sale
Those headline numbers describe two different realities. A strong order book speaks to demand for Nel's offerings; it says nothing about when, or whether, that demand turns into turnover. The revenue line and the negative EBITDA show what the company is currently delivering. An investor betting on a turnaround is effectively underwriting future execution, and the latest top-line performance offers no confirmation of that bet yet.
The decisive yardstick, then, is how quickly the backlog flows into revenue. What would make the recovery case genuinely persuasive is a period in which higher sales coincide with an improvement in operating results. A growing order book without corresponding progress would leave the thesis short of support. The sharp percentage gain in orders deserves attention, but it cannot substitute for advances in the underlying business.
Should investors sell immediately? Or is it worth buying Nel ASA?
The US Order Is the Concrete Anchor
The most tangible support for the optimistic scenario arrived on 13 October, when Nel Hydrogen US reported an order from an unnamed global technology group headquartered in the United States. The customer booked several containerized PEM electrolysers from the MC series, together with associated services. The order is valued at roughly USD 12 million, with delivery expected in 2027.
That is a firm order rather than a loose collaboration, which matters. If Nel executes as planned, the contract could feed into future revenue and demonstrate that it can move demand for such solutions into shipped equipment. Execution, not the receipt of the purchase order, is what counts. No delivery has taken place, and no earnings improvement is assured.
A second avenue could open through the cooperation agreed with Rheinmetall around two weeks ago. The two companies intend to run a feasibility study into decentralized production of synthetic fuels from renewable hydrogen, with Nel contributing electrolyser technology and Rheinmetall its Giga-PtX concept and system integration. In a favourable outcome, further business opportunities could follow. As things stand, the arrangement is a non-binding declaration of intent, not a confirmed order — and a feasibility review must not be mistaken for secured follow-on business. Even a positive study result would not automatically become a purchase order.
Losses Keep the Pressure On
The bear case does not require orders to dry up. It gains weight simply if the higher intake fails to translate into better operating performance. Liquidity of NOK 1,078 million gives management room to manoeuvre, but cash on hand is no substitute for an improvement in the running business. Should revenue stay weak despite the fuller backlog, that would be a serious counterargument to the recovery narrative: fresh orders would prove demand while delivering too little economic effect.
Nor can a larger order intake be read directly as a sign of better margins. Only fulfilment can show whether the additional business eases the loss-making position. The risk for shareholders therefore lies not solely in orders that fail to materialize, but equally in a disappointing conversion of the orders already won.
Nel ASA at a turning point? This analysis reveals what investors need to know now.
A New Hand on the Wheel From 1 November
The next fixed date on the calendar is 1 November 2026, when finance chief Kjell Christian Bjørnsen is due to take over as interim group CEO. Torbjørn Berg steps in as interim finance chief. Morten Holum, named as successor to Håkon Volldal, is scheduled to assume the top job no later than 1 May 2027.
That transition is an organizational milestone, not evidence of a business recovery in itself. Deriving a brighter outlook from the appointment of a new chief executive would be premature; a credible re-rating would need operational progress alongside it. The managerial handover sets the timing, while execution of the order book remains the economic test — including the 2027 delivery to the US technology customer, which will ultimately be judged on its contribution to the business.
For now, the backlog keeps the positive scenario alive. Should operating development stay weak despite the stronger orders, that foundation will not be enough to justify a more favourable valuation. Investors face a clear trade-off: the order picture opens opportunities, but Nel still has to deliver the economic proof.
Ad
Nel ASA Stock: New Analysis - 24 October
Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
